Human Metabolome Technologies, Inc.(JP:6090)
Â¥571.00-2.00 (-0.35%)
JP:6090
Human Metabolome Technologies, Inc. financials statements
Â¥571.00
At close:-2.00 (-0.35%)
Want to see JP:6090 full AI Analyst Report?
Human Metabolome Technologies, Inc. (6090) Ratios
1 Followers
Human Metabolome Technologies, Inc. Ratios
JP:6090's free cash flow for Q4 2025 was ¥0.00. For the 2025 fiscal year, JP:6090's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.03 | 4.14 | 3.31 | 3.75 | 3.19 |
| Quick Ratio | 3.97 | 4.03 | 3.25 | 3.70 | 3.11 |
| Cash Ratio | 3.29 | 3.54 | 2.83 | 3.36 | 2.75 |
| Solvency Ratio | 0.69 | 0.77 | 0.50 | 0.71 | 0.57 |
| Operating Cash Flow Ratio | 0.48 | 0.83 | 0.37 | 0.58 | 0.59 |
| Short-Term Operating Cash Flow Coverage | 2.09 | 3.73 | 1.18 | 1.42 | 1.62 |
| Net Current Asset Value | ¥ 1.32B | ¥ 1.40B | ¥ 1.44B | ¥ 1.33B | ¥ 1.16B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.05 | 0.09 | 0.10 | 0.11 |
| Debt-to-Equity Ratio | 0.06 | 0.06 | 0.12 | 0.13 | 0.16 |
| Debt-to-Capital Ratio | 0.05 | 0.05 | 0.10 | 0.11 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.25 | 1.24 | 1.34 | 1.29 | 1.39 |
| Debt Service Coverage Ratio | 2.91 | 3.32 | 1.64 | 1.82 | 1.66 |
| Interest Coverage Ratio | 105.86 | 99.88 | 105.09 | 93.15 | 86.34 |
| Debt to Market Cap | 0.03 | 0.02 | 0.05 | 0.05 | 0.05 |
| Interest Debt Per Share | 18.71 | 19.24 | 38.63 | 38.74 | 39.90 |
| Net Debt to EBITDA | -4.17 | -4.20 | -4.46 | -4.47 | -3.86 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.08% | 63.37% | 64.60% | 66.17% | 68.67% |
| EBIT Margin | 14.76% | 17.18% | 19.62% | 18.42% | 21.59% |
| EBITDA Margin | 22.59% | 24.26% | 26.03% | 24.60% | 26.90% |
| Operating Profit Margin | 14.76% | 17.11% | 16.36% | 16.24% | 15.63% |
| Pretax Profit Margin | 15.80% | 18.49% | 19.46% | 18.24% | 21.41% |
| Net Profit Margin | 14.09% | 17.59% | 18.08% | 21.99% | 21.89% |
| Continuous Operations Profit Margin | 14.09% | 17.59% | 18.08% | 21.99% | 21.89% |
| Net Income Per EBT | 89.17% | 95.17% | 92.88% | 120.57% | 102.24% |
| EBT Per EBIT | 107.04% | 108.03% | 118.96% | 112.33% | 137.02% |
| Return on Assets (ROA) | 8.79% | 10.78% | 9.34% | 12.47% | 12.94% |
| Return on Equity (ROE) | 10.95% | 13.41% | 12.50% | 16.12% | 18.01% |
| Return on Capital Employed (ROCE) | 11.40% | 12.94% | 11.17% | 11.73% | 12.56% |
| Return on Invested Capital (ROIC) | 9.63% | 11.66% | 9.36% | 10.49% | 11.03% |
| Return on Tangible Assets | 8.92% | 10.84% | 9.40% | 12.59% | 12.98% |
| Earnings Yield | 5.82% | 5.69% | 6.55% | 6.46% | 6.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.52 | 8.51 | 5.90 | 10.01 | 7.74 |
| Payables Turnover | 24.95 | 138.08 | 31.68 | 0.00 | 3116.07 |
| Inventory Turnover | 20.07 | 10.42 | 12.88 | 16.76 | 8.83 |
| Fixed Asset Turnover | 5.38 | 5.11 | 4.05 | 4.80 | 5.03 |
| Asset Turnover | 0.62 | 0.61 | 0.52 | 0.57 | 0.59 |
| Working Capital Turnover Ratio | 1.04 | 1.01 | 0.95 | 1.02 | 1.05 |
| Cash Conversion Cycle | 69.73 | 75.28 | 78.71 | 58.25 | 88.39 |
| Days of Sales Outstanding | 66.17 | 42.90 | 61.89 | 36.48 | 47.18 |
| Days of Inventory Outstanding | 18.19 | 35.03 | 28.34 | 21.77 | 41.33 |
| Days of Payables Outstanding | 14.63 | 2.64 | 11.52 | 0.00 | 0.12 |
| Operating Cycle | 84.35 | 77.93 | 90.23 | 58.25 | 88.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 37.17 | 63.52 | 40.05 | 48.26 | 54.92 |
| Free Cash Flow Per Share | 26.47 | 38.32 | 34.28 | 28.47 | 30.15 |
| Dividend Paid and CapEx Coverage Ratio | 1.44 | 1.58 | 2.55 | 1.62 | 2.22 |
| Capital Expenditure Coverage Ratio | 3.47 | 2.52 | 6.94 | 2.44 | 2.22 |
| Operating Cash Flow Coverage Ratio | 2.03 | 3.38 | 1.05 | 1.26 | 1.39 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.26 | 0.18 | 0.22 | 0.26 |
| Free Cash Flow Yield | 4.31% | 5.00% | 5.46% | 3.80% | 4.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 17.19 | 17.57 | 15.27 | 15.48 | 16.08 |
| Price-to-Sales (P/S) Ratio | 2.42 | 3.09 | 2.76 | 3.40 | 3.52 |
| Price-to-Book (P/B) Ratio | 1.88 | 2.36 | 1.91 | 2.50 | 2.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 23.20 | 19.99 | 18.32 | 26.31 | 24.21 |
| Price-to-Operating Cash Flow Ratio | 16.52 | 12.06 | 15.68 | 15.52 | 13.29 |
| Price-to-Earnings Growth (PEG) Ratio | -0.95 | 2.95 | -1.02 | 2.34 | 0.04 |
| Enterprise Value Multiple | 6.55 | 8.54 | 6.14 | 9.36 | 9.23 |
| Enterprise Value | 2.10B | 3.01B | 2.15B | 2.99B | 3.04B |
| EV to EBITDA | 6.55 | 8.54 | 6.14 | 9.36 | 9.23 |
| EV to Sales | 1.48 | 2.07 | 1.60 | 2.30 | 2.48 |
| EV to Free Cash Flow | 14.17 | 13.40 | 10.61 | 17.80 | 17.06 |
| EV to Operating Cash Flow | 10.09 | 8.08 | 9.08 | 10.50 | 9.37 |
| Tangible Book Value Per Share | 320.05 | 322.83 | 326.35 | 296.45 | 250.92 |
| Shareholders’ Equity Per Share | 325.93 | 325.01 | 329.23 | 300.14 | 251.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.11 | 0.05 | 0.07 | -0.21 | -0.02 |
| Revenue Per Share | 253.40 | 247.77 | 227.58 | 220.02 | 207.33 |
| Net Income Per Share | 35.71 | 43.59 | 41.14 | 48.39 | 45.39 |
| Tax Burden | 0.89 | 0.95 | 0.93 | 1.21 | 1.02 |
| Interest Burden | 1.07 | 1.08 | 0.99 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.11 | 0.14 | 0.13 |
| SG&A to Revenue | 0.46 | 0.46 | 0.05 | 0.05 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.04 | 1.46 | 0.90 | 1.00 | 1.21 |
Currency in JPY

